243 related articles for article (PubMed ID: 20355166)
1. Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm.
Goebel C; Howe CJ; Ho KK; Nelson A; Kazlauskas R; Trout GJ
Drug Test Anal; 2009 Nov; 1(11-12):511-7. PubMed ID: 20355166
[TBL] [Abstract][Full Text] [Related]
2. False negative results in testosterone doping in forensic cases: Sensitivity of the urinary detection criteria T/E and T/LH.
Lood Y; Aardal E; Gustavsson S; Prasolov I; Josefsson M; Ahlner J
Drug Test Anal; 2021 Oct; 13(10):1735-1742. PubMed ID: 34228890
[TBL] [Abstract][Full Text] [Related]
3. Effect of administration of human chorionic gonadotrophin on criteria used to assess testosterone administration in athletes.
Cowan DA; Kicman AT; Walker CJ; Wheeler MJ
J Endocrinol; 1991 Oct; 131(1):147-54. PubMed ID: 1744555
[TBL] [Abstract][Full Text] [Related]
4. Criteria to indicate testosterone administration.
Kicman AT; Brooks RV; Collyer SC; Cowan DA; Nanjee MN; Southan GJ; Wheeler MJ
Br J Sports Med; 1990 Dec; 24(4):253-64. PubMed ID: 2097025
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.
Anielski P; Simmchen J; Wassill L; Ganghofner D; Thieme D
Drug Test Anal; 2011 Oct; 3(10):645-51. PubMed ID: 21928278
[TBL] [Abstract][Full Text] [Related]
6. Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone.
Perry PJ; MacIndoe JH; Yates WR; Scott SD; Holman TL
Clin Chem; 1997 May; 43(5):731-5. PubMed ID: 9166223
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases.
Garle M; Ocka R; Palonek E; Björkhem I
J Chromatogr B Biomed Appl; 1996 Dec; 687(1):55-9. PubMed ID: 9001952
[TBL] [Abstract][Full Text] [Related]
8. Influence of multiple human chorionic gonadotropin administrations on serum and urinary steroid Athlete Biological Passport profiles in males.
Goodrum JM; Moore C; Crouch AK; Eichner D; Miller GD
Drug Test Anal; 2023; 15(11-12):1371-1381. PubMed ID: 37749856
[TBL] [Abstract][Full Text] [Related]
9. Reporting and managing elevated testosterone/epitestosterone ratios--novel aspects after five years' experience.
Mareck U; Geyer H; Fusshöller G; Schwenke A; Haenelt N; Piper T; Thevis M; Schänzer W
Drug Test Anal; 2010; 2(11-12):637-42. PubMed ID: 21204295
[TBL] [Abstract][Full Text] [Related]
10. Detection of testosterone doping in female athletes.
Handelsman DJ; Bermon S
Drug Test Anal; 2019 Oct; 11(10):1566-1571. PubMed ID: 31454165
[TBL] [Abstract][Full Text] [Related]
11. Discordant genotyping results using DNA isolated from anti-doping control urine samples.
Choong E; Schulze JJ; Ericsson M; Rane A; Ekström L
Drug Test Anal; 2017 Jul; 9(7):994-1000. PubMed ID: 27706926
[TBL] [Abstract][Full Text] [Related]
12. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids.
Aguilera R; Becchi M; Casabianca H; Hatton CK; Catlin DH; Starcevic B; Pope HG
J Mass Spectrom; 1996 Feb; 31(2):169-76. PubMed ID: 8799270
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis.
van de Kerkhof DH; de Boer D; Thijssen JH; Maes RA
J Anal Toxicol; 2000 Mar; 24(2):102-15. PubMed ID: 10732948
[TBL] [Abstract][Full Text] [Related]
14. Disposition of Urinary and Serum Steroid Metabolites in Response to Testosterone Administration in Healthy Women.
Elings Knutsson J; Andersson A; Baekken LV; Pohanka A; Ekström L; Hirschberg AL
J Clin Endocrinol Metab; 2021 Mar; 106(3):697-707. PubMed ID: 33274381
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
[TBL] [Abstract][Full Text] [Related]
17. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios.
Aguilera R; Chapman TE; Starcevic B; Hatton CK; Catlin DH
Clin Chem; 2001 Feb; 47(2):292-300. PubMed ID: 11159778
[TBL] [Abstract][Full Text] [Related]
18. Testosterone and doping control.
Saudan C; Baume N; Robinson N; Avois L; Mangin P; Saugy M
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
[TBL] [Abstract][Full Text] [Related]
19. Changes in blood parameters after intramuscular testosterone ester injections - Implications for anti-doping.
Solheim SA; Mørkeberg J; Dehnes Y; Hullstein I; Juul A; Upners EN; Nordsborg NB
Drug Test Anal; 2020 Aug; 12(8):1019-1030. PubMed ID: 32307878
[TBL] [Abstract][Full Text] [Related]
20. The influence of small doses of ethanol on the urinary testosterone to epitestosterone ratio in men and women.
Albeiroti S; Ahrens BD; Sobolevskii T; Butch AW
Drug Test Anal; 2018 Mar; 10(3):575-583. PubMed ID: 28671321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
